ПЕРСОНАЛИЗИРОВАННАЯ ОЦЕНКА РИСКА ТЯЖЁЛЫХ ФОРМ ВАРИКОЗНОЙ БОЛЕЗНИ ВЕН НИЖНИХ КОНЕЧНОСТЕЙ НА ОСНОВЕ БИОХИМИЧЕСКИХ И ГЕНЕТИЧЕСКИХ ПОКАЗАТЕЛЕЙ
Abstract
Background: Varicose veins of the lower extremities (VVLE) is a chronic, progressive disorder of the venous system. It can lead to chronic venous insufficiency and trophic disorders, which significantly impair a patient's quality of life. Despite extensive research on individual biochemical and genetic factors, integrated prognostic models for personalized risk assessment of severe forms of the disease remain lacking. Objective: To evaluate biochemical and genetic factors associated with severe forms of VVLE (classes C4-C6 according to the CEAP classification) to develop a personalized risk stratification approach. Methods: This observational comparative study included 371 patients with VVLE. Of these, 187 patients had clinical classes C2-C3, and 184 had classes C4-C6. All patients underwent duplex ultrasound scanning of the lower extremity veins. Peripheral venous blood levels of E-selectin, MCP-1, MMP-2, VEGF, and MMP-9 were determined using an enzyme-linked immunosorbent assay (ELISA). Genotyping of 13 single-nucleotide polymorphisms was performed using real-time PCR. Results: Patients with severe disease were significantly older and had higher levels of all studied biochemical markers (p<0.001). Independent predictors for the development of classes C4-C6 were patient age, the levels of MMP-9 (OR=1.248), MMP-2 (OR=1.015), and VEGF (OR=1.016), as well as the genetic polymorphisms VEGFA rs2010963, MMP2 rs243865, and COL1A1 rs1800012. The combined predictive model demonstrated high discriminatory ability (AUC=0.91) with a sensitivity of 81% and a specificity of 88%. Conclusion: The developed model enables personalized risk assessment of varicose vein progression. It can identify patients at high risk of developing severe forms of the disease early. Keywords: Varicose veins, chronic venous insufficiency, biochemical markers, genetic polymorphisms, risk prediction.